These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1925812)

  • 21. Perindopril: a review of its use in patients with or at risk of developing coronary artery disease.
    Curran MP; McCormack PL; Simpson D
    Drugs; 2006; 66(2):235-55. PubMed ID: 16451098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular effects of ACE inhibition by perindopril.
    Michel JB; Levy BI
    Drugs; 1990; 39 Suppl 1():39-42. PubMed ID: 2407491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of perindopril: therapeutic consequences.
    Lees KR; Hughes DM; McNeill CA; Reid JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():31-4. PubMed ID: 2505711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension.
    Wiseman LR; McTavish D
    Drugs; 1994 Jul; 48(1):71-90. PubMed ID: 7525196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
    Middeke M; Krone W
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
    Morin JP; Moulin B; Borghi H; Fillastre JP
    Int J Tissue React; 1989; 11(2):81-92. PubMed ID: 2559047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perindopril safety and tolerance in at-risk patients.
    Brichard S; Lambert AE
    Drugs; 1990; 39 Suppl 1():64-70. PubMed ID: 2407494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.
    Grislain L; Mocquard MT; Dabe JF; Bertrand M; Luijten W; Marchand B; Resplandy G; Devissaguet M
    Xenobiotica; 1990 Aug; 20(8):787-800. PubMed ID: 2219962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
    de Leeuw PW; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic and regional hemodynamic interactions of perindopril and nitrendipine in the spontaneously hypertensive rat.
    Scalbert E; Narcisse G; Abdon D; Fauchère JL; Santoni JP
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):676-83. PubMed ID: 1691399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects.
    Louis WJ; Workman BS; Conway EL; Worland P; Rowley K; Drummer O; McNeil JJ; Harris G; Jarrott B
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):505-11. PubMed ID: 1279299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertension and the renin-angiotensin system. The role of perindopril. 1st international Coversyl symposium. Paris, 29 October 1988. Proceedings].
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():1-94. PubMed ID: 2505707
    [No Abstract]   [Full Text] [Related]  

  • 35. Interdependence of food intake and angiotensin converting enzyme inhibition on kidney function.
    Corman B; Michel JB
    J Hypertens Suppl; 1988 Dec; 6(3):S65-8. PubMed ID: 3225691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
    Tsai HH; Lees KR; Howden CW; Reid JL
    Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects.
    Abdel-Haq B; Magagna A; Favilla S; Salvetti A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S33-6. PubMed ID: 1725198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of perindopril in high-risk populations.
    Resplandy G; Genissel P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S9-18. PubMed ID: 1725203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension, the renin-angiotensin system and perindopril. First International Symposium on Perindopril. Paris, France, October 29, 1989.
    Clin Exp Hypertens A; 1989; 11 Suppl 2():459-623. PubMed ID: 2605797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.